Various Mechanisms Cause RET-mediated Signaling Defects in Hirschsprung's Disease
Abstract
Hirschsprung's disease (HSCR) is a common congenital malformation characterized by the absence of intramural ganglion cells of the hindgut. Recently, mutations of the RET tyrosine kinase receptor have been identified in 50 and 15-20% of familial and sporadic HSCR, respectively. These mutations include deletion, insertion, frameshift, nonsense, and missense mutations dispersed throughout the RET coding sequence. To investigate their effects on RET function, seven HSCR missense mutations were introduced into either a 1114-amino acid wild-type RET isoform (RET51) or a constitutively activated form of RET51 (RET-MEN 2A). Here, we report that one mutation affecting the extracytoplasmic cadherin domain (R231H) and two mutations located in the tyrosine kinase domain (K907E, E921K) impaired the biological activity of RET-MEN 2A when tested in Rat1 fibroblasts and pheochromocytoma PC12 cells. However, the mechanisms resulting in RET inactivation differed since the receptor bearing R231H extracellular mutation resulted in an absent RET protein at the cell surface while the E921K mutation located within the catalytic domain abolished its enzymatic activity. In contrast, three mutations mapping into the intracytoplasmic domain neither modified the transforming capacity of RET-MEN 2A nor stimulated the catalytic activity of RET in our ligand-independent system (S767R, P1039L, M1064T). Finally, the C609W HSCR mutation exerts a dual effect on RET since it leads to a decrease of the receptor at the cell surface and converted RET51 into a constitutively activated kinase due to the formation of disulfide-linked homodimers. Taken together, our data show that allelic heterogeneity at the RET locus in HSCR is associated with various molecular mechanisms responsible for RET dysfunction. (
Related
- GDNF enemas improve epithelial and immune defects in both aganglionic and ganglionic colon of Hirschsprung mice
- A multiscale signaling–biophysical framework reveals mechanisms of macrophage-mediated RBC clearance in sickle cell and Gaucher disease
- Early Insulin Signaling Defects and Oxidative Stress Kinase Activation Precede Tau Pathology in PS19 Tau Transgenic Mice
- A model of the locust visual system under diverse stimuli highlights functionality of various mechanisms and suggests a parsimonious structure
- Comparative profiling of MAIT cells across gastrointestinal cancers identifies conserved NK receptor dysregulation and HCC-specific defects in cytotoxicity and XBP1s signaling
BibTeX
@article{pelet2026various,
title = {{Various Mechanisms Cause RET-mediated Signaling Defects in Hirschsprung's Disease}},
author = {Anna Pelet and Olivier Geneste and Patrick Edery and Andrea Pasini and Sophie Chappuis and Tania Attié and Arnold Munnich and Gilbert Lenoir and Stanislas Lyonnet and Marc Billaud},
journal = {Journal of Clinical Investigation},
year = {2026},
month = oct,
url = {https://hal.science/hal-05790510v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Various Mechanisms Cause RET-mediated Signaling Defects in Hirschsprung's Disease
AU - Anna Pelet
AU - Olivier Geneste
AU - Patrick Edery
AU - Andrea Pasini
AU - Sophie Chappuis
AU - Tania Attié
AU - Arnold Munnich
AU - Gilbert Lenoir
AU - Stanislas Lyonnet
AU - Marc Billaud
PY - 2026
DA - 2026/10/10
JO - Journal of Clinical Investigation
UR - https://hal.science/hal-05790510v1
AB - Hirschsprung's disease (HSCR) is a common congenital malformation characterized by the absence of intramural ganglion cells of the hindgut. Recently, mutations of the RET tyrosine kinase receptor have been identified in 50 and 15-20% of familial and sporadic HSCR, respectively. These mutations include deletion, insertion, frameshift, nonsense, and missense mutations dispersed throughout the RET coding sequence. To investigate their effects on RET function, seven HSCR missense mutations were introduced into either a 1114-amino acid wild-type RET isoform (RET51) or a constitutively activated form of RET51 (RET-MEN 2A). Here, we report that one mutation affecting the extracytoplasmic cadherin domain (R231H) and two mutations located in the tyrosine kinase domain (K907E, E921K) impaired the biological activity of RET-MEN 2A when tested in Rat1 fibroblasts and pheochromocytoma PC12 cells. However, the mechanisms resulting in RET inactivation differed since the receptor bearing R231H extracellular mutation resulted in an absent RET protein at the cell surface while the E921K mutation located within the catalytic domain abolished its enzymatic activity. In contrast, three mutations mapping into the intracytoplasmic domain neither modified the transforming capacity of RET-MEN 2A nor stimulated the catalytic activity of RET in our ligand-independent system (S767R, P1039L, M1064T). Finally, the C609W HSCR mutation exerts a dual effect on RET since it leads to a decrease of the receptor at the cell surface and converted RET51 into a constitutively activated kinase due to the formation of disulfide-linked homodimers. Taken together, our data show that allelic heterogeneity at the RET locus in HSCR is associated with various molecular mechanisms responsible for RET dysfunction. (
SN - 0021-9738
ER -